Search hospitals > Quebec > SHERBROOKE
DIEX Recherche Sherbrooke, Inc
Claim this profileSHERBROOKE, Quebec J1L 0H8
Conducts research for Alzheimer's Disease
Conducts research for Atopic Dermatitis
Conducts research for Psoriasis
Conducts research for Eczema
Conducts research for Diabetes
87 reported clinical trials
3 medical researchers
Summary
DIEX Recherche Sherbrooke, Inc is a medical facility located in SHERBROOKE, Quebec. This center is recognized for care of Alzheimer's Disease, Atopic Dermatitis, Psoriasis, Eczema, Diabetes and other specialties. DIEX Recherche Sherbrooke, Inc is involved with conducting 87 clinical trials across 95 conditions. There are 3 research doctors associated with this hospital, such as Marcel Germain, Marylene Dussault, and Daniel Minier.Area of expertise
1Alzheimer's Disease
donanemab
Aβ1-42 positive
Aβ1-40 positive
2Atopic Dermatitis
Top PIs
Marcel GermainDiex Recherche Sherbrooke Inc.3 years of reported clinical research
Studies Alzheimer's Disease
Studies Dementia
2 reported clinical trials
2 drugs studied
Marylene DussaultDiex Recherche Sherbrooke Inc.2 years of reported clinical research
Studies Alzheimer's Disease
1 reported clinical trial
2 drugs studied
Daniel MinierDIEX Recherche Sherbrooke Inc.1 year of reported clinical research
Studies Systemic Lupus Erythematosus
Studies Cutaneous Lupus Erythematosus
1 reported clinical trial
3 drugs studied
Clinical Trials running at DIEX Recherche Sherbrooke, Inc
Vitiligo
Depression
Systemic Lupus Erythematosus
Major Depressive Disorder
Migraine
Thrombocytopenic Purpura
Dermatomyositis
Bullous Pemphigoid
Antiphospholipid Syndrome
Cardiovascular Disease
Ritlecitinib
for Vitiligo
This trial is testing ritlecitinib, a medicine for treating vitiligo, in adults with nonsegmental vitiligo. The medicine works by protecting skin color cells from being destroyed by the immune system. The study will compare ritlecitinib to see if it is safe and effective. Ritlecitinib is being tested for its efficacy in treating alopecia areata and vitiligo.
Recruiting1 award Phase 310 criteria
MK-6194
for Vitiligo
This trial is testing a new medication called MK-6194 to see if it can help people with non-segmental vitiligo. The goal is to determine if MK-6194 can reduce the white patches on their skin by helping repigment these areas. Researchers will compare the results over several months.
Recruiting0 awards Phase 26 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at DIEX Recherche Sherbrooke, Inc?
DIEX Recherche Sherbrooke, Inc is a medical facility located in SHERBROOKE, Quebec. This center is recognized for care of Alzheimer's Disease, Atopic Dermatitis, Psoriasis, Eczema, Diabetes and other specialties. DIEX Recherche Sherbrooke, Inc is involved with conducting 87 clinical trials across 95 conditions. There are 3 research doctors associated with this hospital, such as Marcel Germain, Marylene Dussault, and Daniel Minier.